Kui Xu

发表

Discovery and structure-activity relationship studies of indole derivatives as liver X receptor (LXR) agonists.

Chiaki Fukushima, Kei Takedomi, K. Takedomi, 2007, Bioorganic & medicinal chemistry letters.

2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.

J. Zapf, I. Sircar, F. Bakir, 2007, Bioorganic & medicinal chemistry letters.

Identification of novel series of human CCR1 antagonists.

J. Li, I. Sircar, Kui Xu, 2008, Bioorganic & medicinal chemistry letters.

Placental tissue stem cells and their role in neonatal diseases.

V. Kalinichenko, Kui Xu, A. Damianos, 2021, Seminars in fetal & neonatal medicine.

Sensitive and simultaneous detection of multi-index lung cancer biomarkers by an NIR-Ⅱ fluorescence lateral-flow immunoassay platform

Tao Liao, Lijiao Ao, Kui Xu, 2022, Chemical Engineering Journal.

Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.

Chiaki Fukushima, Kei Takedomi, K. Takedomi, 2008, Journal of medicinal chemistry.

TLR8 agonist Motolimod-induced inflammatory death for treatment of acute myeloid leukemia.

Kaiqing Liu, Kui Xu, Xiaoru Huang, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo

E. Gulbins, M. Bachmann, I. Szabó, 2023, Journal of Molecular Medicine.

Bifunctional PEGylated exenatide-amylinomimetic hybrids to treat metabolic disorders: an example of long-acting dual hormonal therapeutics.

Soumitra S Ghosh, C. Jodka, D. Parkes, 2013, Journal of medicinal chemistry.

Identification of novel series of human CCR1 antagonists.

J. Li, I. Sircar, Kui Xu, 2008, Bioorganic & medicinal chemistry letters.